Nicolas Hulscher, MPH Profile picture
Epidemiologist and Administrator at the McCullough Foundation (@mcculloughfund). Stay informed: https://t.co/TvcBHYRjPt
Jun 5 5 tweets 3 min read
💥With 341 references, our landmark study DESTROYS the 3 biggest COVID-19 "vaccine" myocarditis myths still pushed by public health agencies.

Time to set the record straight with facts.

A thread (1/5)🧵 Image (2/5)
Myth #1: SARS-CoV-2 infection causes more myocarditis than COVID-19 mRNA vaccination.

❌ False.

➡️ Men under 40 were 6× more likely to get myocarditis after 2nd Moderna dose vs. infection (97 vs. 16/million)

➡️ 223× spike in VAERS myocarditis reports after COVID-19 shots vs. 30-year vaccine average (2,500% increase)

➡️ 90% of PubMed case reports (241/267) from May 2021–Nov 2024 identified the vaccine—not infection—as cause

➡️ Infection-linked myocarditis often based on ICD-10 codes + elevated troponins (non-specific)

➡️ Troponins can be elevated due to CAD, heart failure, ICU stress—not myocarditis

➡️ Most infection cases lacked confirmation by MRI, biopsy, or autopsy

➡️ CARES Act paid hospitals ~$76K per COVID case, incentivizing overdiagnosis

➡️ True COVID infection rates were undercounted (asymptomatic cases), inflating infection-related myocarditis ratesImage
Jan 9 4 tweets 6 min read
THREE Grounds for COVID-19 'Vaccine' Market Withdrawal Have Been Fulfilled

1. DNA Contamination - Multiple independent studies worldwide have repeatedly confirmed the presence of DNA contamination in vaccine vials across various brands and batches.

2. Negative Efficacy - Five studies establish that 'vaccinated' individuals ultimately face a higher risk of infection compared to those who are not.

3. Excess Mortality - Twelve studies and VAERS have demonstrated that the 'vaccines' increase risk of death and have contributed to excess mortality worldwide.

The evidence is overwhelming—any one of these three grounds should demand immediate market withdrawal of the COVID-19 injections. EXCESS MORTALITY SOURCES:

1. VAERS COVID Vaccine Adverse Event Reports. OpenVAERS. Published September 6, 2024. openvaers.com/covid-data
2. Hulscher N, Alexander P E., Amerling R, et al. A Systematic Review Of Autopsy Findings In Deaths After COVID-19 Vaccination. Science, Public Health Policy and the Law. 2024 Nov 17; v5.2019-2024
3. Rancourt DG, Baudin M, Hickey J, et al. COVID-19 Vaccine Associated Mortality in the Southern Hemisphere. Journal of Research and Applied Medicine. 2023. doi: 10.55634/2.2.10
4. Mostert S, Hoogland M, Huibers M, et al. Excess mortality across countries in the Western World since the COVID-19 pandemic: ‘Our World in Data’ estimates of January 2020 to December 2022: BMJ Public Health 2024;2:e000282. doi: 10.1136/bmjph-2023-000282
5. Skidmore M. COVID-19 Illness and Vaccination Experiences in Social Circles Affect COVID-19 Vaccination Decisions. Science, Public Health Policy and the Law. 2023 Oct 02; v4.2019-2024
6. Pantazatos S, Seligmann H. COVID vaccination and age-stratified all-cause mortality risk. Research Gate 2021 Oct 26. Epub Oct 26. DOI: 10.13140/RG.2.2.28257.43366
7. Hulscher, N., Cook, M. J., Stricker, R. B., McCullough, P. A. (2024). Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington. J Emerg Med OA, 2(1), 01-11. doi: 10.33140/JEMOA.02.01.12
8. Aarstad J, Kvitastein OA. Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality? Asian Pac. J. Health Sci., 2023;10(1):25-31. doi:10.21276/apjhs.2023.10.1.6
9. Alessandria M, Malatesta GM, Berrino F, Donzelli A. A Critical Analysis of All-Cause Deaths during COVID-19 Vaccination in an Italian Province. Microorganisms. 2024;12(7):1343. Published 2024 Jun 30. doi:10.3390/microorganisms12071343
10. Lataster R. European Excess Mortality Correlates with COVID-19 Vaccination into 2024. Bulgarian Medicine. vol. 13 no. 2/2023. basa.bg/en/images/Br_0
11. Allen DE. The correlation between Australian excess deaths by state and booster vaccinations. Med Res Arch. 2024;12(7). doi:10.18103/mra.v12i7.5485
12. Kuhbandner C, Reitzner M. Differential increases in excess mortality in the German federal states during the COVID-19 pandemic. ResearchGate. 2024. doi:10.13140/RG.2.2.13098.18880
13. Rodrigues NCP, Andrade MK de N. Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term. Front Med (Lausanne). 2024;11. doi:10.3389/fmed.2024.1495428